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In the course of studying the ST2 gene, which was initially found to be expressed specifically at the C&G, transitional state in BALBlc-3T3 cells 
and was one of the primary response genes, we found another ST2-related mRNA, designated as STZL, in serum-stimulated BALB/c-3T3 cells 
in the presence of cycloheximide. Nucleotide sequence analysis of the cloned STZL cDNA revealed that it had an open reading frame encoding 
a polypeptide of 567 amino acids. A 5’ region (1,028 nucleotides) of STZL cDNA was identical with the ST2 cDNA, and a unique 3’ region encoded 
‘a putative transmembrane domain of 24 amino acids and a cytoplasmic domain of 201 amino acids. The ST2 gene product is highly similar to 
the extracellular portion of IL-I receptors type 1 and type 2, and the STZL gene product shows a marked similarity with entire IL-l receptor 
type I. 
Interleukin 1 receptor; Cell growth; Primary response gene; Immunoglobulin superfamily 
1. INTRODUCTION from Amersham. AZAP II phage was from Stratagene. Taq DNA 
polymerase was from Perkin-Elmer Cetus Instruments. 
Growth stimulation induces a number of genes to 
produce proteins that regulate cell proliferation. We 
have recently been focusing on the ST2 gene, one of the 
primary response genes expressed in BALB/c-3T3 cells 
specifically at the GJG, transitional state [1,2]. The 
amino acid sequence deduced from ST2 cDNA is highly 
similar to the extracellular portion of IL-l receptors 
[1,3]. In the course of studying the expression mecha- 
nisms of ST2, we found another mRNA of about 5 kb 
that hybridized with ST2 cDNA [2]. Here we report the 
presence of a novel STZrelated cDNA (tentatively 
named ST2L), the deduced amino acid sequence of 
which has a putative transmembrane and cytoplasmic 
domain and shows marked similarity with IL-l receptor 
type 1 as a whole molecule. 
Total cytoplasmic RNAs were extracted from BALB/c-3T3 cells 20 
h after the stimulation with 10% calf serum in the presence of IO@ml 
of cycloheximide. Poly(A) RNAs were prepared as described [4]. Com- 
plementary DNA synthesis was performed using the cDNA synthesis 
system plus kit, and the cDNAs longer than approximately 3.5 kb were 
selected after agarose gel electrophoresis to exclude any contamina- 
tion by ST2 cDNA (2.7 kb). The size-selected cDNAs were used to 
construct a cDNA library in AZAP II phage, and then a 1.6-kb H&II 
fragment of ST2 cDNA was used as a probe for plaque hybridization 
[l]. Positive clones were subjected to in vivo excision according to the 
company’s protocol, and the nucleotide sequence of the resultant 
plasmid (Bluescript II) containing insert of longer than 4-kb was 
determined as mentioned previously [1,4]. 
The PCR (94°C for 1 min, 50°C for 2 min, and 72°C for 3 mm) was 
performed in 30 cycles m the presence of Taq polymerase. Northern 
blot analysis was performed as described [4]. Alignment of predicted 
amino-acid sequences of ST2L and murine IL-lR1 was carried out by 
the FASTA program [5]. 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
The BALB/c-3T3 cells (clone A31) were gift from Dr. C. Stiles 
(Harvard Medical School). The multiprime DNA labelling system, the 
cDNA synthesis ystem plus kit, [a-3ZP]dCTP, and [a-35S]dCTP were 
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A 1.6-kb HincII fragment of ST2 cDNA was used to 
screen a size-selected cDNA library derived from stimu- 
lated BALB/c-3T3 cells [l]. Three positive clones ob- 
tained out of 110,000 independent clones had a common 
structure with ST2 on the 5’ side and a unique structure 
on the 3’ side. Even the longest clone contained only a 
partial ST2 sequence, starting from the point corre- 
sponding to the 23rd amino acid of the predicted amino 
acid sequence of ST2 protein. To study whether the 
S-flanking region of these clones were identical with 
that in ST2, we employed PCR. As shown in Fig. lb, 
the Pl primer started from T, 42 nucleotides upstream 
of the initiation codon of ST2 cDNA. The downstream 
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Fig. 1. Identification of the 5’-flanking region of ST2L cDNA by PCR. 
Panel a: PCR products were analyzed by 5% polyacrylamide gel elec- 
trophorests and visualized by ethidtum bromide staining. A srze-se- 
lected cDNA library (lanes 1 and 2) or ST2 cDNA (lanes 3 and 4) was 
used as a template. Primers are described in Panel b. Panel b: arrows 
indicate the positions of Pl (5’-TGCCATTGCCATAGAGAGAC- 
3’) P2 (5’-TCAAGCAATGTGTGAGGGAC-3’). and P3 (5’- 
GTAGATGCTTCGGTGATCAA-3’) primers. Cross-hatched re- 
gions represent the common sequence found in ST2 and ST2L 
cDNAs. The area surrounded by the dotted hne corresponds to the 
portion verified by PCR. The 5’ non-coding regton of ST2 cDNA 
(striped area), a putative transmembrane domam of STZL cDNA 
(TM), and a putative cytoplasmic domain of ST2L cDNA (dotted 
area) are shown. 
primers P2 and P3 were specific for ST2 and ST2L 
cDNA, respectively. With Pl and P3, a band of appro- 
priate length was found on the gel (Fig. la, lane 2). 
Nucleotide sequence analysis after cloning the DNA 
fragment revealed that ST2 and ST2L had the same 
sequence around the initiation codon (Fig. 2, oblique 
letters). Whole nucleotide sequence analysis of the long- 
est clone together with the result of the PCR experiment 
revealed that ST2L cDNA consisted of 4,989 bases and 
shared an identical 5’ region of 1,028 nucleotides with 
ST2 until just before the stop codon of ST2 cDNA (the 
boxed region in Fig. 2). and then started a unique nucle- 
otide sequence thereafter (Fig. 2). ST2L cDNA coded 
for a protein consisting of 567 amino acids that has a 
putative transmembrane domain of 24 amino acids 
(Fig. 2, underlined) and a cytoplasmic domain of 201 
amino acids. Three AUUUA mRNA destabilizing se- 
quences were found in the 3’-untranslated region of 
ST2L cDNA (Fig. 2) [6]. 
Northern blotting analysis was performed with two 
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Fig. 3. The transcripts detected by the probes derived from ST2 and 
ST2L cDNAs. Panel a: four micrograms of total RNAs extracted from 
quiescent BALB/c-3T3 cells (lanes 1 and 3) or from cells 20 h after 
serum stimulation (lanes 2 and 4) were analyzed by Northern blotting. 
Panel b: schematic representation of the probes for Northern hybrid- 
ization. Probe A corresponds to the 1.6-kb H1ncI1 fragment of ST2 
cDNA and probe B is a fragment (nucleotide number of 1,057 to 
1,827) of STZL cDNA. Cross-hatched regions are common in ST2 and 
STZL cDNAs. TM denotes the transmembrane domain. 
probes (Fig. 3). With probe A, which could hybridize 
to both ST2 and ST2L, two bands appeared in the case 
of serum stimulated cells (Fig. 3a, lane 2) as previously 
described [2]. On the other hand, ST2L specific probe 
B hybridized only to the upper band (Fig. 3a, lane 4). 
confirming that the cloned ST2L cDNA corresponded 
to the 5 kb mRNA which was expressed in growth 
stimulated BALB/c-3T3 cells. 
A computer search of the GenBank database identi- 
fied significant similarities of ST2L over 500 amino 
acids with murine, human, and chicken IL-lR1. The 
sequence identity between ST2L and murine IL-l Rl 
was 28% over the whole molecules (Fig. 4a). We pointed 
out that the ST2 gene product corresponding to the 
putative extracellular portion of ST2L had a 25% amino 
acid identity with the extracellular portion of murine 
IL- 1 R 1 [ 11; and subsequently, murine IL- 1 R2 was also 
found to share 23% amino acid identity with ST2 [3]. AS 
for the cytoplasmic portion, ST2L and murine IL-l R 1 
had a higher similarity of 38%. while ST2L showed no 
84 
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similarity with the cytoplasmic region of IL-lR2 (Fig. 
4b). 
Among a battery of IL-1R related proteins reported, 
a product of vaccinia virus has recently been shown to 
be a soluble IL-1R [7,8]. Other soluble IL-l binding 
proteins remain to be studied [9,10]. ST2 was initially 
found to be a GJG,-specific gene coding for a protein 
1183 C-KTACGATGC~ACATCA'RTACCcTC GGGPerPCCGGGGWLGCGCGGGGAACCcAC 
381 LeU?).rAspAla~rIleIle~~ProRrgValPheArgHi~ 
1243 TCTGTGGAGTACTITGCZ,CWI'GcCCGAC~ TAAATGT-AC 
401 SerValGlu~rPheVslHisHisThrLeuProkspValL~ 
1363 AGCAGTATCCAGAATAG GGTGTTETICTGGCCCCTCACATGA'ECACAGC 
441 SerSerIleGlnAanSerArqArqGlnV~lPh~V~l~~lsProHi~He~etHisSer 
highly similar to the extracellular portion of IL-1R [l]. 
An identical cDNA was reported as Tl, which was 
induced by serum and oncoproteins [11,12]. We further 
characterized the genomic DNA of murine ST2 and 
revealed that the St2 locus is tightly linked to the II-lrl 
and II-lr2 loci on mouse chromosome one, suggesting 
the strong relationship between ST2 and IL-1Rs [3,13]. 
1423 AAGGAATXGCCT ACGAGCAGGAGA TIY;C?Y3n;CACAGCGcCCcATCcAG4ACAACTCC 
461 LysGluPheAlaTyrGluGlnGluIleAlaCeuHisSerAl~uIl~Gl~s~s~Ser 
1483 AAGG'EAI-F.XTATEAAAXGAGCC~ TGAGGCMG‘XGACTACAGG'l-KG%GAC 
481 LysValIleLeuIlffiluHetGluProLeuGlyGl~l~Ser~q~uGlnValGlyAsp 
1543 CTGCAAGA-GCATCITGIYjAAAATPCAGGGGAT 
501 LeuGl~pGerLcuGlnH~~~uV~lLy.IleGlnGlyThrIleLysTr~qGl~sp 
1603 CATGTGGCCGTAAGTICcAAA TEIGGAAGCATGTGAGGTACCAAATG 
521 HisValAlaAspLysGlnSerLeuSerSerLysPheTrpLy=Hi~V~~q~=Gl~=t 
1663 CCAGTGCCAGAAAGA~XICCAAGACGGCA~-C~GI~ GGCTCCGTl'GAGTGGCAAGGCA 
541 ProValPrffiluArqAlaSerLysThrAlaSesValAlaA~GlyLY~Ala 
1723 'PGCITAGACCRIRRRCACITI?Y;RGTM;RW\GCn;CGG 
561 CysLe"A.,pLeuLys"i,Phe l 
1783 GIGcAmGA cTIGAAATGccAAGGGTGGozGc CCCAAGWTCAGCTMAGAGCA 
1843 ACTCTA~A~C’AT~TAGGAGCCACCCATCPTPCCGGTITCC~ 
1903 TRXTACT ACAAGATCAACCCTGAGCTC~~A~TC 
19 6 3 TCTRYTGITCC!TKTRT~~AAAA~‘~TAT~~~TACC~ 
2023 AJWGTTATCCCCCTICCCGCCCCXTACAAA~CCCA~C~CCTCC'KCC 
2083 TGCTTCTA'IW&GGTGCCCCCCCACCTGcCcATCCACTCCAGcC'ITAcAGGXTTGKXT 
2143 CCCCTA- 'PCGAGCCTCCATAAC~CCTCCCCTC~A~~~~~AT~TAC 
2203 AT-XXAATA'ICAAGcCGTI-lT~~GA~ GACAGGGTTTCT 
2263 -AGcCCTAmCCA -CTcC~CTCirGA 
2323 RATCAGCCPGCCTCIY;CCTCCCC~G~T~~~G~~~C~C~C~ 
2383 CTAAGCCTACACTlTC4 GAATAAA _G EIG 'I-F.XCCTCAAAGAGCAG~~~CcAG 
2443AGGCRGAGAGCCGGAAAGAGCClWAATGTGcTETC CA'XCAGACJ.XGACC'ITATITGC 
2503 ITACCAGPCACAGGNAACAAAGC GFI-KTCCGTGI'KCCT AGACATCCCTGTAA 
2563 TAGATTA~GCGAAKX3cCGWCTACTGACcA "FFXTGAATI'GTGGTAGARRRAGC 
2623 Gl-EACGl-ITGm AAATACTRXTAGCAATGCCTCATTCCTAACACACC 
2683 CITAC~A~G~ACC~~~GT~GTA~~CA~~~~~GA 
2743 ATACCTTACCCAAATTGCCATTACAGTCGAGCA TGTITKAGITCTAAATGCCTPITnTA 
2803 TATI=TTlT ATPCTIT~AGAAATAC~C~C~~GTAATGTAAG 
2863 AAAACATIU~MGAGA~T~TAAAATATAA~~ 
2923 ATATAA 'IGAAMTCATAACTCTTAAGATTAATT?TGGT AGGTWGTATTITAAAATATAA 
3103 AAA'ETCTCAT'TITAG W\CTATGGC~‘~GCAGC~A-TGAG~~A(; 
3163 GTCTGCCATGXACATXGGA~ATRICCI'A~TTA CXAAA~ATCTGTCACTGTC~GA 
3223 CAGCTAA- TACITCTAXAAATGTGTAGGGAATI-IGGACAGAAU,GAATCAA 
3293 TCTATAGTCAGAGGTCCKX-GGAcAGT ~~~GCACACA~GACCGTGXGTCC 
3343 TAGGCACCCAOGARACGGATCCAGAGCCCAGGCM FETC'lTACAGGTACCTI'GARmP 
3403 GCCAATAGATA~~CC~A~G~T~~C~~~C~~T 
~~~~GAGGIGAW&EAACA~AGZ,ATI~%GAGA~GGA GGGGAA'FX-EAACTCAC 
3523 GCGTAT~~G~~~A~~~A~GT 
3583 AGCCCG' GTGWXTCTI'AGTCACCC'ITA-GCCAGGT 
3643 AAACATI-IWTA GTGTEAGTICAAAGGcTGAA GCTKAGcTGAGGGTGATGA~~~ 
3703 AAAmCCcTCGCAmTcCAcccTGl~m Tl-XCTAAGT"XACCTG':TCT 
3763 CCTGTAGTAGAAKWFI'XATC 'ITCECAK~KTAC~AGTGAG~GCCAAAA 
3823 CTGACCACCATAAC TW"ZKATGKCCAGAACGTG'XATcAG 
3883 GAGGAAGK~~ccGATAACGGAATC CTPGCPCIV;~;GCIY;R;AGTCCCTTA 
3943 GCAACCKAGATAO~AA?TI~TCPTA G~~~~I(;ATGGAR~TA~~~GT~xTGGATIcx-I 
4003 TGCTAACM TAGAAGTA?TCGTr~T-TAAATlrl 
4063 TGATl'ATGAAATCTCATIGTGAGCC~~ -ATXCA~;A~GCTG 
4123 AATGAAGACCTCTAAAAATGMNTCTCFXAATCTCATCC~TAGTTWXTC~T 
4183 CATGCcIcIcpGcTccRxCA TGGUAA"XACTAAAGAGAATTATTAT-,-IGTTCC,XAGAT 
4243 KTKXAT-TAAACAACTA TlTGCAKZAATTGAGcTGTG‘%AcA~ 
4303 AWCAGA- TCTCXlGAGlTTCXXCCAGC CTGCTCTACAGAGTTAGTITC 
4363 AC&AcACcAGA~AcAAAAA GAAAACCKT"XTAACAACAACAGCAAcAGCTGCAGCAG 
4423 CAACAACAACAACAAA GAAAAAGAAGAGGAGGAcmGGAAAmGAAGGAA~&-m 
4403 GAAGAMWjGAAGlrMTA ~AATGAA~A~CATATGCTITGATG~TTT 
4543 TGCTMAC'KAAAA TATI'AGTI-ITAT-I'ITA~TGAAA WXTCAAAGCATGATCCAT 
4603 GTAAAAA'&TCI?TTTCCCAWKTA -CCCcTcATrrCTTCA 
4663 AAG~;CITO~CCAGGCAG~A~~AC~~A~~T~-~GT 
4723 TI'CCTC ~CPCTIY?~AGCCA~~A-~~~CGTCC 
4783 TACTGTCCAGT7XXGAGITCTGr;TAGAAAGAG TGTXAAGTlTGlTAAATGCTTITT 
4843 CCAT'ZATCAAAA TGITAIGCCITIC~ATTGTATGACAAA~ATTITTCACT 
4903 GGGCAAAAATAATX'XC CATIGACTC-CmWG,,GT 
4963 KTAGCTT~~XXAG 
Fig. 2. Complementary DNA sequence and deduced amino acid sequence for STZL. The boxed region indicates the common sequence of ST2 and 
ST2L. The nucleotide sequence shown in oblique letters corresponds to the portion determined by PCR and subsequent sequencing. The putative 
transmembrane domain is underlined. The stop codon is indicated by an asterisk. The poly(A) signals (underlined) and three mRNA destabilizing 
sequences (AUUUA) (boxed) are shown in the 3’ non-coding region. 
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Fig. 4. Comparison of the structures of STZL to closely related molecules. Panel a: ammo-acid residues are shown in smgle-letter code. Vertical 
lines represent he identical amino acid residues, and double dots Indicate high similartty. The transmembrane domains of each protein are 
underlined. Panel b: schematic representation ofST2L-related proteins. Cross-hatched regions of the proteins indicate the similarity of extracellular 
domams of IL-lR1, IL-lR2, and ST2L. ST2 is also almost identical with the extracellular domain of ST2L. Striped areas of IL-IRl (solid hne) 
and ST2L (dotted line) represent a high similarity of cytoplasmic domains. 
The IL-I binding activity of ST2 and STZL is now being transduction of cell proliferation 121. Physiological roles 
investigated; at present, ST2L remains as a possible of ST2 and STZL are now under investigation with 
‘orphan’ receptor. ‘overexpression’ and ‘gene targeting’ procedures. 
Several soluble receptors and binding proteins for 
cytokines and lymphokines have been identified. The 
secreted receptors for human C-CSF, GM-CSF, IL-5 
and IL-7 are derived from an internal deletion of 
mRNAs [14-171. Based on the sequence data of ST2 
genomic DNA, the soluble form (ST2) cannot be gener- 
ated by deletion 1131. Further analysis of the exon- 
intron organization of ST2 and ST2L is necessary to 
elucidate any possible involvement of alternative splic- 
ing. 
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